---
title: What an AI agent reads on CeleCor Therapeutics · The Direct Index
url: https://directindex.org/r/celecor.com/agent-view?format=md
---

[The Direct Index](https://directindex.org/)
[Scanner](https://directindex.org/scan)[Cities](https://directindex.org/cities)[Rankings](https://directindex.org/rankings)[Search](https://directindex.org/search)[Guides](https://directindex.org/guides)[About](https://directindex.org/about)

 [Report](https://directindex.org/r/celecor.com) · scanned 2026-10-16

# What an AI agent reads on CeleCor Therapeutics

An assistant's crawler fetches the page once, without running JavaScript, and reads the text, the structured data and the links. This is that view of [celecor.com](https://celecor.com/), from the copy the scanner kept.

2,002

characters of text without JavaScript

Organization

structured data for the business

0

of 3 AI crawlers turned away at the edge

 Text

## The words an agent gets

Title: Home - CeleCor Therapeutics · language en-US. First 1,800 of 2,002 characters:

```
Home - CeleCor Therapeutics Skip to content Primary Menu Home About zalunfiban(Disaggpro™ ) Clinicaldevelopment CeleBratetrial results About us News Follow us Download Backgrounder Home About zalunfiban (Disaggpro™) Clinical development CeleBrate trial results About us News Follow us Download Backgrounder Every moment counts when treating a patient with a heart attack. About zalunfiban Zalunfiban is an investigational next-generation GPIIb/IIIa platelet inhibitor that was specifically designed for pre-hospital treatment of STEMI heart attacks and is injected subcutaneously (under the skin). Zalunfiban reaches maximal effect within 15 minutes and its antiplatelet effect wears off in about two hours. 1[1] Bentur OS, et al. Assessing the Pharmacodynamics of RUC-4 (zalunfiban), a Novel αIIbβ3 Antagonist, Using VerifyNow Assays in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Treated with Aspirin and Ticagrelor [abstract]. Res Pract Thromb Haemost. 2021; 5 (Suppl 1). About zalunfiban Zalunfiban is an investigational agent; it has not been approved for any use and its safety and efficacy have not been established. Addressing the time-to-treatment gap Potential for rapid heart attack treatment in multiple pre-PCI settings About Us Each year, 800,000 people in the United States have an acute myocardial infarction (AMI), or heart attack. We founded CeleCor Therapeutics to improve the treatment of ST-Segment Elevated Myocardial Infarctions (STEMI heart attacks) at the first point of medical contact. More about us CeleCor Headquarters 1155 Camino Del Mar Suite 481 Del Mar, CA, 92014 contact@celecor.com ©2026 CeleCor Therapeutics, All Rights Reserved. Home About zalunfiban (Disaggpro™ ) Clinical development CeleBrate trial results About us News Download Back
```

 Facts

## What it can state about the business

| A business type in JSON-LD | Organization |
| Name | CeleCor Therapeutics |
| Telephone | no |
| Address | no |
| Opening hours | no |
| Menu or price list | nothing |
| Cuisine in structured data | no |
| JSON-LD blocks | 1 (BreadcrumbList, EntryPoint, ImageObject, ListItem, Organization, PropertyValueSpecification) |

 Actions

## The links it would act on

No booking or ordering link found. An agent has nothing to act on.

Everything here comes from one fetch of the homepage as a crawler; the [report](https://directindex.org/r/celecor.com) turns it into a score and fixes, with a kit to paste.

#### The Direct Index

[Why direct](https://directindex.org/why)[What agent-direct means](https://directindex.org/agent-direct)[About and principles](https://directindex.org/about)[Methodology](https://directindex.org/methodology)[Privacy](https://directindex.org/privacy)[Terms](https://directindex.org/terms)

#### Use it

[Free scanner](https://directindex.org/scan)[City indexes](https://directindex.org/cities)[Search the index](https://directindex.org/search)[Rankings](https://directindex.org/rankings)[What assistants recommend](https://directindex.org/assistants)[Ask the index](https://directindex.org/ask)

#### Vendors and help

[Booking and ordering vendors](https://directindex.org/vendors)[Do their terms allow agents?](https://directindex.org/vendors/terms)[Vendor verification](https://directindex.org/vendors/verification)[Website builders](https://directindex.org/builders)[Who can fix this](https://directindex.org/providers)[For agencies](https://directindex.org/agency)

#### For agents

[llms.txt](https://directindex.org/llms.txt)[llms-full.txt](https://directindex.org/llms-full.txt)[OpenAPI](https://directindex.org/openapi.json)[MCP server](https://directindex.org/.well-known/mcp/server-card.json)[A2A agent](https://directindex.org/.well-known/agent-card.json)[Direct feeds](https://directindex.org/direct.json)

#### Data

[Open data, CSV and JSON](https://directindex.org/data)[The quarterly edition](https://directindex.org/editions)[City data, JSON and Markdown](https://directindex.org/cities)[Sitemap](https://directindex.org/sitemap.xml)

Business listings from OpenStreetMap contributors, ODbL. Scores under the same licence.

```json
{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://directindex.org/#org","name":"The Direct Index","url":"https://directindex.org/","logo":"https://directindex.org/favicon.svg","founder":{"@type":"Person","name":"Antonio Curado"},"description":"Independent measurement of whether AI agents can find, read and act on a business's own website."},{"@type":"WebSite","@id":"https://directindex.org/#site","url":"https://directindex.org/","name":"The Direct Index","publisher":{"@id":"https://directindex.org/#org"},"inLanguage":"en","potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://directindex.org/scan?url={url}"},"query-input":"required name=url"}},{"@type":"WebAPI","name":"The Direct Index API","url":"https://directindex.org/openapi.json","documentation":"https://directindex.org/llms-full.txt","provider":{"@id":"https://directindex.org/#org"}}]}
```